Gilead Sciences to Present at the 2008 Citi Investment Research Global Healthcare Conference on Wednesday, May 21
May 14 2008 - 4:15PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its
corporate presentation will be webcast from the 2008 Citi
Investment Research Global Healthcare Conference in New York. This
webcast may be accessed via the company�s corporate website at
www.gilead.com. John F. Milligan, PhD, Gilead�s President and Chief
Operating Officer, will provide an overview of the company on
Wednesday, May 21 at 10:30 a.m. Eastern Time. To access the live
webcast via the internet log on to www.gilead.com. Please connect
to the company�s website at least 15 minutes prior to the start of
the presentation to ensure adequate time for any software download
that may be necessary to listen to the webcast. About Gilead Gilead
Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet
medical need. The company�s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia. For more information on Gilead
Sciences, please visit www.gilead.com or call the Gilead Public
Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024